List

S.Suman1, P. Karthikeyan2, S.Moulishankar3,  S.Sridhar4, G. Raaja5*, G.S. Aathithiah6, M.Vetriselvan7, Joemon8, R.Pachiyappan9,  B. Devendran10

Authors:
1Managing Director, Vijayani Nutraceuticals Pvt Ltd, 2Director, Vijayani Nutraceuticals Pvt Ltd, 3Director, Vijayani Nutraceuticals Pvt Lt, 4  Principal Research Investigator, Ashram Siddha Research Institute, 5Medical Officer, Vijayani Nutraceuticals Pvt Ltd, 6Medical Officer, Vijayani Nutraceuticals Pvt Ltd, 7General Manager, Vijayani Nutraceuticals Pvt Ltd, 8Manufacturing Incharge, Vijayani Nutraceuticals Pvt Ltd, 9Product Development, Oriens Global Marketing Pvt Ltd, 10 Pharmacologist, Vijayani Nutraceuticals Pvt Ltd
Corresponding Author:
*Dr. G. Raaja, Medical Officer, Vijayani Nutraceuticals Pvt. Ltd., Chennai, Tamil Nadu, India.
Email ID: raaja.ayurdoctor@gmail.com

Abstract

Introduction: Obesity and hypercholesterolemia are significant global health concerns, contributing to metabolic disorders such as cardiovascular disease and type 2 diabetes. Conventional treatments often include pharmacological interventions and lifestyle modifications, which may have limitations in terms of adherence and side effects. Ayurvedic medicine offers a holistic approach to weight management and metabolic regulation. DELIPO CAPSULE, a proprietary Ayurvedic formulation, has been developed to address symptoms associated with obesity, including shortness of breath, fatigue, excessive sweating,, difficulty in sleeping and high LDL cholesterol levels.  Objective: The primary objective of this study was to evaluate the clinical efficacy of DELIPO CAPSULE in managing symptoms of obesity and hypercholesterolemia.

Methods: The study aimed to assess its impact on weight management, cholesterol levels, and associated symptoms over a 30-day treatment period.  This Phase-II-A, single-center, open-label, therapeutic exploratory clinical trial was conducted on 20 patients diagnosed with obesity-related conditions. Participants were administered 1-2 DELIPO CAPSULES twice daily with lukewarm water for 30 days. Clinical and laboratory assessments were performed at baseline (day-1) and post-treatment (day-30). Ethical approval was obtained, and written informed consent was secured from all participants.

Results: After 30 days of treatment: 75% (15 patients) experienced significant symptom improvement. 15% (3 patients) showed moderate improvement. 5% (1 patient) had mild improvement. 5% (1 patient) dropped out of the study. Laboratory investigations confirmed improvements in cholesterol levels and metabolic markers.

Conclusion: DELIPO CAPSULE demonstrated significant efficacy in managing obesity-related symptoms and metabolic imbalances. The findings support its potential as a safe and effective Ayurvedic intervention for weight management and hypercholesterolemia.
Keywords: Obesity, Hypercholesterolemia, Metabolic disorders, Ayurvedic medicine
Received on 29th January 2025; Revised on 18th   February 2025; Accepted on 28th February 2025, DOI:10.36678/IJMAES.2025.V11I01.002

Leave a Reply

Your email address will not be published. Required fields are marked *

  Posts

1 … 9 10 11 … 43
October 17th, 2026

How Casino Conflict Resolution Systems Shield Players and Operators Alike

The online gaming industry has seen significant growth, bringing with it the necessary task of managing disputes among players and […]

October 17th, 2026

How Device-Level Content Filtering Tools Protects Children from Dangerous Web Material

In today’s era, children have unprecedented access to online content, making parental oversight increasingly difficult. non GameStop casinos provides a […]

October 17th, 2026

VPN Usage in Online Gambling: Reasons Gamblers Visit Platforms Globally

The online world of wagering has transformed dramatically, with millions of players looking for international platforms regardless of geographical restrictions. […]

October 17th, 2026

Neues Internet-Kasino geht online mit großzügigen Bonus-Paketen und neuester Gaming-Technologie

Die online Glücksspielbranche erlebt einen weiteren Meilenstein: Ein Neues Online Casino eröffnet seine digitalen Pforten und bietet Spielern aus Deutschland […]

October 17th, 2026

Online-Wetten außerhalb von OASIS: Zulässige Alternativen bei internationalen Betreibern

Das OASIS-Sperrsystem limitiert deutsche Spieler zunehmend ein, doch Online Wetten ohne OASIS bieten legale Möglichkeiten für Wettinteressierte. Internationale Wettanbieter mit […]

October 17th, 2026

Glücksspiel ohne OASIS: Freier Zugriff zu globalen Buchmachern

Die deutsche Wetten-landschaft hat sich durch die Einführung des OASIS-Sperrsystems grundlegend verändert. Zahlreiche Wettbegeisterte auf der Suche nach Alternativen, da […]

October 17th, 2026

Understanding the legal environment and Safety of offshore poker platforms on the internet

The world of digital poker has grown substantially, with best online casinos becoming an increasingly popular option for players seeking […]

October 17th, 2026

Grasping Regulatory Concerns and Perks of Playing in Offshore Poker Rooms

The online environment of poker platforms has grown substantially, with UK online casino offering players gaming options and competitive events […]

October 17th, 2026

Enhancing AML Controls in Online Gaming: Critical Compliance Strategies

The accelerating development of virtual gaming environments has created notable avenues for money laundering, making best casinos not on GamStop […]

October 17th, 2026

Key Strategies for Enhancing Your Horse Racing Betting Success Rate

Success in online casinos UK requires more than mere chance; it necessitates a disciplined methodology combining thorough research, disciplined bankroll […]